A team led by researchers at Temple University School of Medicine (TUSM) found that a commonly prescribed antidepressant restored heart function in mice with heart failure, a finding that could lead to clinical trials for ...
Mar 4, 2015
3
221
Patients who receive more cells get significant benefits. That's a key lesson emerging from a clinical trial that was reported this week at the American Heart Association meeting in Chicago.
Nov 21, 2014
0
0
(HealthDay)—Non-ablative fractional laser treatment may provide long-term improvement of mature burn scars, according to research published online Aug. 22 in Lasers in Surgery and Medicine.
Sep 12, 2014
0
0
Clinicians have been urged to consider using spironolactone in their patients with heart failure and preserved ejection fraction (HFPEF) after a post-hoc analysis of the TOPCAT trial showed benefit in patients from the Americas.
May 18, 2014
0
0
(HealthDay)—Four treatments with 1,440-nm fractional laser produce mild improvement in select signs of photodamage in an Asian population, according to a study published March 14 in Lasers in Surgery and Medicine.
Apr 10, 2014
0
0
Findings from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, have revealed that adding the medication known as spironolactone (Aldactone) to existing therapy did not ...
Apr 9, 2014
0
0
A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found that a simple blood test can predict a person's risk for sudden cardiac death, enabling physicians to more quickly ...
Apr 2, 2014
0
1
Johns Hopkins researchers have identified a new way to predict which heart failure patients are likely to see their condition get worse and which ones have a better prognosis. Their study is one of the first to show that ...
Dec 11, 2013
0
0
Two drugs tested in a larger trial did not improve kidney function in acute heart failure patients, contrary to results of smaller studies. The results were presented today at the American Heart Association's Scientific Sessions ...
Nov 18, 2013
0
0
A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, ...
Nov 18, 2013
0
0
